Browse All

Current Filters

CLEAR FILTER x

TITLE

Author Institution:

Design of ADAPT FORWARD, a Phase 2a Study to Evaluate the Safety, Efficacy, and Tolerability of Intravenous Empasiprubart as an Add-on Therapy to Intravenous Efgartigimod in Adult Participants with Generalized Myasthenia Gravis

Treatment of Extracellular Antibody-mediated Autoimmune Encephalitis with Efgartigimod in Real-world Clinical Practice: Targeted Literature Review and Meta-analysis